Logo image of MELE.BR

MELEXIS NV (MELE.BR) Stock Fundamental Analysis

EBR:MELE - Euronext Brussels - BE0165385973 - Common Stock - Currency: EUR

66.2  -0.1 (-0.15%)

Fundamental Rating

6

MELE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the health and profitability get an excellent rating, making MELE a very profitable company, without any liquidiy or solvency issues. MELE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

MELE had positive earnings in the past year.
In the past year MELE had a positive cash flow from operations.
In the past 5 years MELE has always been profitable.
In the past 5 years MELE always reported a positive cash flow from operatings.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

MELE has a better Return On Assets (19.17%) than 89.09% of its industry peers.
Looking at the Return On Equity, with a value of 30.21%, MELE is in the better half of the industry, outperforming 78.18% of the companies in the same industry.
With an excellent Return On Invested Capital value of 23.13%, MELE belongs to the best of the industry, outperforming 85.45% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MELE is significantly above the industry average of 15.29%.
The last Return On Invested Capital (23.13%) for MELE is well below the 3 year average (31.03%), which needs to be investigated, but indicates that MELE had better years and this may not be a problem.
Industry RankSector Rank
ROA 19.17%
ROE 30.21%
ROIC 23.13%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

Looking at the Profit Margin, with a value of 18.38%, MELE is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
In the last couple of years the Profit Margin of MELE has grown nicely.
MELE has a better Operating Margin (23.57%) than 63.64% of its industry peers.
MELE's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 43.03%, MELE perfoms like the industry average, outperforming 41.82% of the companies in the same industry.
MELE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.57%
PM (TTM) 18.38%
GM 43.03%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MELE is creating value.
Compared to 1 year ago, MELE has about the same amount of shares outstanding.
The number of shares outstanding for MELE has been increased compared to 5 years ago.
Compared to 1 year ago, MELE has a worse debt to assets ratio.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

MELE has an Altman-Z score of 8.17. This indicates that MELE is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 8.17, MELE is doing good in the industry, outperforming 69.09% of the companies in the same industry.
The Debt to FCF ratio of MELE is 1.78, which is an excellent value as it means it would take MELE, only 1.78 years of fcf income to pay off all of its debts.
MELE has a Debt to FCF ratio of 1.78. This is in the better half of the industry: MELE outperforms 61.82% of its industry peers.
MELE has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MELE (0.38) is worse than 65.45% of its industry peers.
Although MELE does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 1.78
Altman-Z 8.17
ROIC/WACC2.12
WACC10.92%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

MELE has a Current Ratio of 4.54. This indicates that MELE is financially healthy and has no problem in meeting its short term obligations.
MELE has a Current ratio of 4.54. This is amongst the best in the industry. MELE outperforms 87.27% of its industry peers.
A Quick Ratio of 2.01 indicates that MELE has no problem at all paying its short term obligations.
The Quick ratio of MELE (2.01) is better than 74.55% of its industry peers.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 2.01
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

MELE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.50%.
The Earnings Per Share has been growing by 23.04% on average over the past years. This is a very strong growth
MELE shows a decrease in Revenue. In the last year, the revenue decreased by -9.03%.
MELE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.89% yearly.
EPS 1Y (TTM)-32.5%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-53.44%
Revenue 1Y (TTM)-9.03%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-18.02%

3.2 Future

Based on estimates for the next years, MELE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.39% on average per year.
MELE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.12% yearly.
EPS Next Y-25.62%
EPS Next 2Y-0.54%
EPS Next 3Y4.79%
EPS Next 5Y10.39%
Revenue Next Year-11.57%
Revenue Next 2Y0.06%
Revenue Next 3Y3.24%
Revenue Next 5Y5.12%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.75, MELE is valued on the expensive side.
Based on the Price/Earnings ratio, MELE is valued a bit cheaper than 74.55% of the companies in the same industry.
MELE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.34.
With a Price/Forward Earnings ratio of 15.82, MELE is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MELE indicates a somewhat cheap valuation: MELE is cheaper than 70.91% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, MELE is valued a bit cheaper.
Industry RankSector Rank
PE 18.75
Fwd PE 15.82
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MELE is valued a bit cheaper than the industry average as 65.45% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, MELE is valued cheaper than 85.45% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.38
EV/EBITDA 10.72
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

MELE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.81
EPS Next 2Y-0.54%
EPS Next 3Y4.79%

5

5. Dividend

5.1 Amount

MELE has a Yearly Dividend Yield of 3.88%.
MELE's Dividend Yield is rather good when compared to the industry average which is at 1.28. MELE pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, MELE pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.88%

5.2 History

On average, the dividend of MELE grows each year by 10.98%, which is quite nice.
Dividend Growth(5Y)10.98%
Div Incr Years3
Div Non Decr Years6
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

MELE pays out 87.19% of its income as dividend. This is not a sustainable payout ratio.
The dividend of MELE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP87.19%
EPS Next 2Y-0.54%
EPS Next 3Y4.79%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

MELEXIS NV

EBR:MELE (6/19/2025, 7:00:00 PM)

66.2

-0.1 (-0.15%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-30 2025-07-30
Inst Owners15.6%
Inst Owner ChangeN/A
Ins Owners25.01%
Ins Owner ChangeN/A
Market Cap2.67B
Analysts77.78
Price Target64.96 (-1.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.88%
Yearly Dividend3.7
Dividend Growth(5Y)10.98%
DP87.19%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.09%
Min EPS beat(2)-38.45%
Max EPS beat(2)-1.73%
EPS beat(4)1
Avg EPS beat(4)-9.23%
Min EPS beat(4)-38.45%
Max EPS beat(4)9.1%
EPS beat(8)4
Avg EPS beat(8)-4.63%
EPS beat(12)7
Avg EPS beat(12)-0.24%
EPS beat(16)10
Avg EPS beat(16)2.37%
Revenue beat(2)0
Avg Revenue beat(2)-4.03%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-2.83%
Revenue beat(4)0
Avg Revenue beat(4)-2.93%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.68%
Revenue beat(8)1
Avg Revenue beat(8)-2.02%
Revenue beat(12)4
Avg Revenue beat(12)-1.17%
Revenue beat(16)6
Avg Revenue beat(16)5.08%
PT rev (1m)3.7%
PT rev (3m)-3.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.35%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.25%
Valuation
Industry RankSector Rank
PE 18.75
Fwd PE 15.82
P/S 2.87
P/FCF 21.38
P/OCF 15.01
P/B 4.71
P/tB 4.72
EV/EBITDA 10.72
EPS(TTM)3.53
EY5.33%
EPS(NY)4.18
Fwd EY6.32%
FCF(TTM)3.1
FCFY4.68%
OCF(TTM)4.41
OCFY6.66%
SpS23.09
BVpS14.05
TBVpS14.02
PEG (NY)N/A
PEG (5Y)0.81
Profitability
Industry RankSector Rank
ROA 19.17%
ROE 30.21%
ROCE 27.83%
ROIC 23.13%
ROICexc 24.13%
ROICexgc 24.17%
OM 23.57%
PM (TTM) 18.38%
GM 43.03%
FCFM 13.41%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
ROICexc(3y)38.83%
ROICexc(5y)36.08%
ROICexgc(3y)39.06%
ROICexgc(5y)36.42%
ROCE(3y)37.33%
ROCE(5y)34.27%
ROICexcg growth 3Y-14.81%
ROICexcg growth 5Y1.87%
ROICexc growth 3Y-14.47%
ROICexc growth 5Y2.21%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
F-Score5
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 1.78
Debt/EBITDA 0.8
Cap/Depr 111.24%
Cap/Sales 5.69%
Interest Coverage 20.46
Cash Conversion 66.58%
Profit Quality 72.96%
Current Ratio 4.54
Quick Ratio 2.01
Altman-Z 8.17
F-Score5
WACC10.92%
ROIC/WACC2.12
Cap/Depr(3y)136.47%
Cap/Depr(5y)110.04%
Cap/Sales(3y)6.76%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.5%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-53.44%
EPS Next Y-25.62%
EPS Next 2Y-0.54%
EPS Next 3Y4.79%
EPS Next 5Y10.39%
Revenue 1Y (TTM)-9.03%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-18.02%
Revenue Next Year-11.57%
Revenue Next 2Y0.06%
Revenue Next 3Y3.24%
Revenue Next 5Y5.12%
EBIT growth 1Y-15.83%
EBIT growth 3Y13.74%
EBIT growth 5Y24.11%
EBIT Next Year-15.16%
EBIT Next 3Y8.75%
EBIT Next 5Y10.24%
FCF growth 1Y236.29%
FCF growth 3Y6.64%
FCF growth 5Y13.04%
OCF growth 1Y5817.76%
OCF growth 3Y7.8%
OCF growth 5Y13.55%